Skip to main content
FinSpry Logo
FinSpry
EXEL logo
EXEL
(NASDAQ)
Exelixis, Inc.
$54.08-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Exelixis (EXEL) Stock Price & Financial Analysis

Exelixis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$53.70 - $54.68
52-Week High$57.57
52-Week Low$33.76
Open$53.74
Volume1.95M
Average Volume (3M)2.52M
Market Cap13.99B
Shares Outstanding258.63M
P/E Ratio (TTM)15.75
Forward P/E12.40
Price to Sales (P/S)5.60
Price to Book (P/B)6.99
EV/EBITDA13.21
Revenue (TTM)2.42B
Net Income (TTM)859.04M
Free Cash Flow (TTM)1.12B
EPS (TTM)$3.16
Profit Margin35.53%
Operating Margin40.30%
Return on Equity (ROE)44.38%
Debt to Equity0.09
50-Day MA$54.13
200-Day MA$46.60
52-Week Change36.57%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Exelixis

What is the current stock price for EXEL?

As of the latest trading session, EXEL stock trades at $54.08. The 52-week range is $33.76–$57.57, with a day range of $53.70–$54.68.

What is the P/E ratio for EXEL?

Exelixis's trailing P/E ratio is 15.8, meaning investors pay $15.8 for every $1 of annual earnings. The forward P/E is 12.4, reflecting analyst expectations for future earnings. Exelixis operates in the Healthcare sector.

Does EXEL pay dividends?

Exelixis does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EXEL?

Based on 9 analysts, the consensus for EXEL is Hold.

What is the market cap of EXEL?

Exelixis's market capitalization is $13.99B, classifying it as a large-cap company. Exelixis operates in the Healthcare sector within the Biotechnology industry.